News

Scientists may have found way to prevent constipation in Parkinson’s

Interactions between receptors for ghrelin, the so-called hunger hormone, and the chemical signaling molecule dopamine may go awry in Parkinson’s disease, potentially leading to chronic constipation — a symptom that the Australian scientists behind this new research called “debilitating” for many people with the condition. To learn more about…

Staying active in hospital speeds recovery, improves outcomes

People with Parkinson’s disease who stay active while in the hospital may recover faster and live longer, according to a study. The research, conducted by the Parkinson’s Foundation in partnership with University Hospitals, found that patients who moved at least three times a day — as the Parkinson’s…

Advocates urge Congress to boost Parkinson’s research funding

More than 250 Parkinson’s patients, family members, scientists, and advocates gathered recently in Washington to urge Congress to expand federal funding for Parkinson’s disease research at the National Institutes of Health (NIH). They were part of the annual Parkinson’s Policy Forum, hosted by organizations including the Michael J. Fox…

Brain chemistry patterns differ in Parkinson’s, essential tremor

Parkinson’s disease and essential tremor are associated with distinct signaling patterns of two key brain neurotransmitters, dopamine and serotonin, according to a new study. These two chemical messengers allow nerve cells to communicate. Using machine learning, researchers analyzed the regulation of neurotransmitter systems during reward-based decision-making, a cognitive process…

MJFF grant supports AI-driven Parkinson’s research

The Michael J. Fox Foundation (MJFF) has awarded a grant to Valo Health to support the development of new treatments targeting the underlying causes of Parkinson’s disease. The funding will allow researchers to use artificial intelligence to uncover the root causes of the disease and identify new…